Vitronectin and Its Receptors Partly Mediate Adhesion of Ovarian Cancer Cells to Peritoneal Mesothelium in vitro (original) (raw)

Skip Nav Destination

Article navigation

Issue Cover

Research Articles| September 09 2008

Loraine Heyman;

aERRMECe, EA 1391, UFR Sciences et Techniques, Cergy-Pontoise,

Search for other works by this author on:

Sabrina Kellouche;

aERRMECe, EA 1391, UFR Sciences et Techniques, Cergy-Pontoise,

Search for other works by this author on:

Julien Fernandes;

aERRMECe, EA 1391, UFR Sciences et Techniques, Cergy-Pontoise,

Search for other works by this author on:

Soizic Dutoit;

bUnité Biologie et Thérapies Innovantes des Cancers Localement Agressifs, Groupe Régional d’Etudes sur le Cancer, EA 1772, Université de Caen-Basse Normandie et Centre de Lutte Contre le Cancer F. Baclesse, Caen, France

Search for other works by this author on:

Laurent Poulain;

bUnité Biologie et Thérapies Innovantes des Cancers Localement Agressifs, Groupe Régional d’Etudes sur le Cancer, EA 1772, Université de Caen-Basse Normandie et Centre de Lutte Contre le Cancer F. Baclesse, Caen, France

Search for other works by this author on:

Franck Carreiras

aERRMECe, EA 1391, UFR Sciences et Techniques, Cergy-Pontoise,

Search for other works by this author on:

Tumor Biology (2008) 29 (4): 231–244.

Content Tools

Abstract

Epithelial ovarian cancer cells metastasize by implanting onto the peritoneal mesothelial surface of the abdominal cavity. Adhesive molecules that lead to this implantation remain unclear. The aim of our study was to focus on the role of vitronectin (Vn) and its receptors, αv integrins and urokinase plasminogen activator receptor (uPAR), in the interactions of ovarian adenocarcinoma cells (IGROV1 and SKOV3 cell lines) with mesothelial cells (MeT-5A cell line and primary cultures). For all cell lines, immunofluorescence staining disclosed the presence of Vn over the whole cell surface and in thin continuous deposits underlining the cell periphery. Recruitment of Vn receptors to cell-cell contact sites was also revealed. We developed two distinct methods for the evaluation of in vitro cell-cell adhesion using cocultures of the tumor and mesothelial cells. Both adhesion assays revealed a strong ability of ovarian cancer cells to adhere preferentially to mesothelial intercellular junctions. Adhesion of ovarian carcinoma cells to mesothelial cells was significantly inhibited using anti-Vn-, -αv-integrin- and -uPAR-blocking antibodies or cyclic peptide cRGDfV. These results evidence the ability of ovarian carcinoma cells to bind to peritoneal mesothelium in vitroand strongly suggest that Vn and its receptors contribute to this crucial event.

This content is only available via PDF.

© 2008 S. Karger AG, Basel

2008

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.

Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

You do not currently have access to this content.

Sign in

Digital Version

Pay-Per-View Access

$45.00

1 Karger Article Bundle Token

$170

Rental

This article is also available for rental through DeepDyve. Read this now at DeepDyve